BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 21733988)

  • 21. Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors.
    Galantino ML; Tiger R; Brooks J; Jang S; Wilson K
    Integr Cancer Ther; 2019; 18():1534735419850627. PubMed ID: 31131640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
    Conejo I; Pajares B; Alba E; Cuesta-Vargas AI
    BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
    Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM
    J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study.
    DeNysschen CA; Burton H; Ademuyiwa F; Levine E; Tetewsky S; O'Connor T
    Eur J Cancer Care (Engl); 2014 Jul; 23(4):493-501. PubMed ID: 24289215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Campbell A; Heydarian R; Ochoa C; Dwivedi AK; Nahleh ZA
    Breast J; 2018 May; 24(3):260-268. PubMed ID: 29442401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.
    Chen L; Lin CC; Huang TW; Kuan YC; Huang YH; Chen HC; Kao CY; Su CM; Tam KW
    Breast; 2017 Jun; 33():132-138. PubMed ID: 28384564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
    Crew KD; Capodice JL; Greenlee H; Brafman L; Fuentes D; Awad D; Yann Tsai W; Hershman DL
    J Clin Oncol; 2010 Mar; 28(7):1154-60. PubMed ID: 20100963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain.
    Nyrop KA; Callahan LF; Rini C; Altpeter M; Hackney B; Schecher A; Wilson A; Muss HB
    Prev Chronic Dis; 2015 Jun; 12():E91. PubMed ID: 26068412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).
    Chan A; De Boer R; Gan A; Willsher P; Martin R; Zissiadis Y; Miller K; Bauwens A; Hastrich D
    Support Care Cancer; 2017 Dec; 25(12):3785-3791. PubMed ID: 28691132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological therapies can relieve aromatase inhibitor-related joint symptoms in breast cancer survivors.
    Zhang Q; Tang D; Zhao H
    Am J Clin Oncol; 2010 Dec; 33(6):557-60. PubMed ID: 20124972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy.
    Peppone LJ; Janelsins MC; Kamen C; Mohile SG; Sprod LK; Gewandter JS; Kirshner JJ; Gaur R; Ruzich J; Esparaz BT; Mustian KM
    Breast Cancer Res Treat; 2015 Apr; 150(3):597-604. PubMed ID: 25814054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.
    Mao JJ; Farrar JT; Bruner D; Zee J; Bowman M; Seluzicki C; DeMichele A; Xie SX
    Cancer; 2014 Dec; 120(23):3744-51. PubMed ID: 25077452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study.
    Cao A; Zhang J; Liu X; Wu W; Liu Y; Fan Z; Zhang A; Zhou T; Fu P; Wang S; Ouyang Q; Tang J; Jiang H; Zhang X; Pang D; He J; Shi L; Wang X; Sheng Y; Mao D; Shao Z
    Health Qual Life Outcomes; 2016 Mar; 14():51. PubMed ID: 27009092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness, safety, and economic evaluation of adjuvant moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer stage I to III patients: Study protocol for a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial.
    Shin S; Jang BH; Park SH; Lee JW; Chae MS; Kim N; Suh HS; Han S; Min SY; Baek SK; Lim YJ; Hwang DS
    Medicine (Baltimore); 2019 Sep; 98(38):e17260. PubMed ID: 31568000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
    Lustberg MB; Orchard TS; Reinbolt R; Andridge R; Pan X; Belury M; Cole R; Logan A; Layman R; Ramaswamy B; Wesolowski R; Berger M; Patterson E; Loprinzi C; Shapiro CL; Yee L
    Breast Cancer Res Treat; 2018 Feb; 167(3):709-718. PubMed ID: 29101597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study.
    Arem H; Sorkin M; Cartmel B; Fiellin M; Capozza S; Harrigan M; Ercolano E; Zhou Y; Sanft T; Gross C; Schmitz K; Neogi T; Hershman D; Ligibel J; Irwin ML
    J Cancer Surviv; 2016 Aug; 10(4):654-62. PubMed ID: 26782031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
    Brier MJ; Chambless DL; Chen J; Mao JJ
    Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of whole-body cryotherapy versus placebo cryotherapy on joint pain induced by aromatase inhibitors in women with early stage breast cancer: a randomised clinical trial.
    Duraes M; Garbay M; Ferrer C; Duflos C; Rathat G
    BMJ Open; 2023 Dec; 13(12):e071756. PubMed ID: 38070928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
    Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL
    Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.